AW
ABUS icon

Avion Wealth’s Arbutus Biopharma ABUS Stock Holding History

Avion Wealth’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7K Hold
1,500
– – ﹤0.01% 680
2026
Q1 		$6K Hold
1,500
– – ﹤0.01% 600
2025
Q4 		$7K Hold
1,500
– – ﹤0.01% 566
2025
Q3 		$6K Hold
1,500
– – ﹤0.01% 589
2025
Q2 		$4K Hold
1,500
– – ﹤0.01% 648
2025
Q1 		$4K Hold
1,500
– – ﹤0.01% 565
2024
Q4 		$4K Hold
1,500
– – ﹤0.01% 563
2024
Q3 		$5K Buy
+1,500
New +$5.75K ﹤0.01% 505

Other funds holding ABUS

TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
WCM
Whitefort Capital Management New York $406M AUM 84.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Avion Wealth's ABUS Position: Q2 2026 in Review

Avion Wealth held its Arbutus Biopharma (ABUS) position steady in Q2 2026 at 1,500 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #680.

Avion Wealth first reported a position in ABUS in Q3 2024 and has held it in 8 quarters since. 177 funds tracked by Wall St. Rank hold ABUS as of Q2 2026.

  • Avion Wealth held 1,500 shares of Arbutus Biopharma worth $7K as of Q2 2026.
  • Avion Wealth left its Arbutus Biopharma share count unchanged in Q2 2026.
  • Arbutus Biopharma made up ﹤0.01% of Avion Wealth's portfolio in Q2 2026, its #680 holding.
  • Avion Wealth first reported a position in Arbutus Biopharma in Q3 2024 and has held it in 8 quarters since.
  • 177 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q2 2026.

Based on Avion Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.